The £200,000 study, funded by the leading charity the Alzheimer’s Research Trust, will aim to find out whether ‘biomarkers’ in blood could be used to identify someone with Alzheimer’s.
A biomarker is a term for something present in the body which can indicate disease, such as a certain protein or molecule. The Nottingham team will be identifying biomarkers by looking at proteins in the blood of Alzheimer’s patients compared to a control group of healthy older people.
Currently, identification of Alzheimer’s disease is difficulty and delays in diagnosis can mean that irreversible damage to the brain has already occurred before treatment can be given.
Doctors believe that catching the disease in its early stages and beginning treatment is a much more effective approach.
Professor Kevin Morgan in The University of Nottingham’s School of Molecular Medical Sciences, said: “A reliable, accurate test to identify affected individuals would mean future treatments could be given much earlier when drugs are likely to be most effective. It would also give people with dementia and their families more time to prepare and plan for the future.”
The researchers at The University of Nottingham hit upon the idea of using biomarkers as a means of diagnosis and will be involved in collecting the samples in conjunction with collaborators in the UK and EU, while the samples will be tested using technology based at Nottingham Trent University.
Rebecca Wood, Chief Executive of the Alzheimer’s Research Trust, said: “We are delighted to be funding what could be a breakthrough study in the diagnosis of Alzheimer’s.
“There are 700,000 people in the UK with dementia and this number is expected to double within a generation. We desperately need to fund research looking at different ways to tackle this devastating disease.”
The news of the study comes shortly before World Alzheimer’s Day on Sunday September 21, which aims to raise awareness about the reality of living with dementia.
Emma Thorne | alfa
New approach for targeted cancer immunotherapy
30.07.2020 | Universität Basel
A new way to target cancers using 'synthetic lethality'
28.07.2020 | University of California - San Diego
“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.
Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...
An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.
Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...
Although no life has been detected on the Martian surface, a new study from astrophysicist and research scientist at the Center for Space Science at NYU Abu...
New approach creates synthetic layered magnets with unprecedented level of control over their magnetic properties
The magnetic properties of a chromium halide can be tuned by manipulating the non-magnetic atoms in the material, a team, led by Boston College researchers,...
Scientists of Tomsk Polytechnic University jointly with a team of the V.E. Zuev Institute of Atmospheric Optics of the Siberian Branch of the Russian Academy of Sciences have discovered a method to increase the operation range of optical traps also known
Optical tweezers are a device which uses a laser beam to move micron-sized objects such as living cells, proteins, and molecules. In 2018, the American...
23.07.2020 | Event News
21.07.2020 | Event News
07.07.2020 | Event News
03.08.2020 | Information Technology
03.08.2020 | Information Technology
03.08.2020 | Life Sciences